Abstract
Background and aimNonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in developed countries, as well as the most common indication for hepatic liver failure in these countries. In this study, we aimed to determine the clinical prognostic significance of the patatin-like phospholipase domain containing 3 (PNPLA3) I148M polymorphism as the genetic dimension in the pathogenesis of NAFLD, the miRNA-122 level as the epigenetic dimension, and to use the miRNA-122 level in NAFLD patients as a biological marker. Material and metodThis study included 40 patients with NAFLD diagnosis who underwent various tests and 20 control groups. At the beginning of the study, the patient's was obtained written informed consent. Age and gender, bady mass ındex (BMI), insulin resistance (IR), aspartate aminotransferase (AST), alanin aminotransferase (ALT) levels were recorded in the patient and control group. ResultsMiRNA-122 level, PNPLA3 I148M polymorphism and various parameters were compared. No statistically significant results were found between miRNA-122 levels when the patient and control group were compared as a result of our study (p = .090). No significant results were found between patient and control group for PNPLA3 I148M polymorphism (p = .087). ConclusionIn the light of this obtained data, progress in NAFLD management will benefit us from further scientific studies in terms of providing new diagnostic biomarkers and therapeutic targets.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
